Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomit...
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
About this item
Full title
Author / Creator
Cao, Jun , Ouyang, Quchang , Wang, Shusen , Ragaz, Joseph , Wang, Xiaojia , Teng, Yuee , Wang, Biyun , Wang, Zhonghua , Zhang, Jian , Wang, Leiping , Wu, Jiong , Shao, Zhimin and Hu, Xichun
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Summary
Background
We examined the efficacy of mirtazapine in preventing delayed nausea and vomiting following highly emetogenic chemotherapy (HEC).
Patients and methods
Patients who had experienced delayed emesis and would be subsequently scheduled for at least three more cycles of the same chemotherapy were randomly assigned to either...
Alternative Titles
Full title
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2376094712
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2376094712
Other Identifiers
ISSN
0167-6997
E-ISSN
1573-0646
DOI
10.1007/s10637-020-00903-8
